Puma – PHARMA
Ex-Puma exec charged with insider trading, hit with criminal charges | Fierce Biotech
Puma Biotechnology, Inc. | LinkedIn
Puma – PHARMA
El negocio bursátil de PUMA BIOTECHNOLOGY – Observatorio de biopolitica
Puma Wins 5-Year Extension of Patent on Main Breast Cancer Treatment Drug Nerlynx - Los Angeles Business Journal
Puma Biotech Strikes Deal to Develop and Market its Breast Cancer Drug in China - Los Angeles Business Journal
Resumen: Puma Biotechnology y Pierre Fabre modifican el acuerdo de licencia de NERLYNX® para incluir la Gran China | Business Wire
PumaBiotech (@pumabiotech) / Twitter
Puma Men – PHARMA
Resumen: Puma Biotechnology y Pierre Fabre modifican el acuerdo de licencia de NERLYNX® para incluir la Gran China | Business Wire
Puma – PHARMA
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Buy Hering Pharma Muira Puma Mother Tincture Q 30ml | ShopHealthy.in
Compra Acciones de Puma Biotechnology Inc y Comprueba ($PBYI) su Precio de Mercado en eToro.
Former Puma Biotech Executive Gets U.S. Prison Term for Insider Trading
Puma Biotechnology
Does Puma's quick Nerlynx launch play into its buyout prospects? | Fierce Pharma
Puma – PHARMA
Puma – PHARMA
Resumen: Puma Biotechnology y Pierre Fabre firman acuerdo de licencia exclusiva para desarrollar y comercializar NERLYNX® (neratinib) en Europa | Business Wire
Resumen: Puma Biotechnology y Pierre Fabre modifican el acuerdo de licencia de NERLYNX® para incluir la Gran China | Business Wire
PharmaBg
